Literature DB >> 23563807

Application of aptamers for targeted therapeutics.

Partha Ray1, Kristi D Viles, Erin E Soule, Rebecca Smock Woodruff.   

Abstract

Aptamers are short, single-stranded oligonucleotides that are isolated through a process termed systematic evolution of ligands by exponential enrichment. With the advent of cell-based selection technology, aptamers can be selected to bind protein targets that are expressed on the cell surface. These aptamers demonstrate excellent specificity and high affinity toward their target proteins and are often internalized upon binding to their targets. This has opened up the possibility of using aptamers for cell-specific targeted drug delivery. In this review, we will discuss cell-surface protein targets, the aptamers that bind them, and their applications for targeted therapeutics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563807     DOI: 10.1007/s00005-013-0227-0

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  13 in total

1.  Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation.

Authors:  William H Thiel; Carla L Esposito; David D Dickey; Justin P Dassie; Matthew E Long; Joshua Adam; Jennifer Streeter; Brandon Schickling; Maysam Takapoo; Katie S Flenker; Julia Klesney-Tait; Vittorio de Franciscis; Francis J Miller; Paloma H Giangrande
Journal:  Mol Ther       Date:  2016-01-06       Impact factor: 11.454

Review 2.  Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.

Authors:  Federico Carbone; Priscila Camillo Teixeira; Vincent Braunersreuther; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  Antioxid Redox Signal       Date:  2014-04-22       Impact factor: 8.401

Review 3.  Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.

Authors:  Jiehua Zhou; John Rossi
Journal:  J Investig Med       Date:  2014-10       Impact factor: 2.895

4.  Anti-KIT DNA Aptamer for Targeted Labeling of Gastrointestinal Stromal Tumor.

Authors:  Jason K Sicklick; Partha Ray; Sudeep Banerjee; Hyunho Yoon; Mayra Yebra; Chih-Min Tang; Mara Gilardi; Jayanth S Shankara Narayanan; Rebekah R White
Journal:  Mol Cancer Ther       Date:  2020-03-03       Impact factor: 6.261

5.  Development of a Soluble KIT Electrochemical Aptasensor for Cancer Theranostics.

Authors:  Saeromi Chung; Jason K Sicklick; Partha Ray; Drew A Hall
Journal:  ACS Sens       Date:  2021-05-19       Impact factor: 9.618

Review 6.  Aptamers: A promising chemical antibody for cancer therapy.

Authors:  Gang Zhou; George Wilson; Lionel Hebbard; Wei Duan; Christopher Liddle; Jacob George; Liang Qiao
Journal:  Oncotarget       Date:  2016-03-22

7.  A DNA aptamer recognising a malaria protein biomarker can function as part of a DNA origami assembly.

Authors:  Maia Godonoga; Ting-Yu Lin; Azusa Oshima; Koji Sumitomo; Marco S L Tang; Yee-Wai Cheung; Andrew B Kinghorn; Roderick M Dirkzwager; Cunshan Zhou; Akinori Kuzuya; Julian A Tanner; Jonathan G Heddle
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

Review 8.  MIPs and Aptamers for Recognition of Proteins in Biomimetic Sensing.

Authors:  Marcus Menger; Aysu Yarman; Júlia Erdőssy; Huseyin Bekir Yildiz; Róbert E Gyurcsányi; Frieder W Scheller
Journal:  Biosensors (Basel)       Date:  2016-07-18

9.  Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Mol Ther Nucleic Acids       Date:  2014-06-17       Impact factor: 10.183

10.  Oligonucleotide aptamers: new tools for targeted cancer therapy.

Authors:  Hongguang Sun; Xun Zhu; Patrick Y Lu; Roberto R Rosato; Wen Tan; Youli Zu
Journal:  Mol Ther Nucleic Acids       Date:  2014-08-05       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.